Literature DB >> 25913668

Downregulation of plasma miR-451 and miR-16 in Plasmodium vivax infection.

Supat Chamnanchanunt1, Chieri Kuroki2, Varunee Desakorn1, Mari Enomoto2, Vipa Thanachartwet1, Duangjai Sahassananda3, Jetsumon Sattabongkot4, Rachaneeporn Jenwithisuk4, Suthat Fucharoen5, Saovaros Svasti5, Tsukuru Umemura6.   

Abstract

Malaria is a common parasitic disease in tropical countries, causing one to two million deaths every year. To establish the new biomarker, we analyzed plasma miRNAs obtained from 19 malaria patients and 19 normal subjects, using reverse transcription-based quantitative polymerase chain reaction (RT-qPCR). The average levels of plasma miR-451 and miR-16 were significantly lower in malaria patients, (8.9-fold; p <0.001 and 10.4-fold; p = 0.01, respectively). The levels of other abundant miRNAs in plasma (miR-223, miR-226-3p) did not change significantly in malaria patients. Our data suggest that plasma miR-451 and miR-16 are relevant biomarkers for malaria infection.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Malaria; Plasma miRNAs; Plasmodium vivax; miR-16; miR-451

Mesh:

Substances:

Year:  2015        PMID: 25913668     DOI: 10.1016/j.exppara.2015.04.013

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  26 in total

1.  Influence of Aspergillus fumigatus conidia viability on murine pulmonary microRNA and mRNA expression following subchronic inhalation exposure.

Authors:  T L Croston; A P Nayak; A R Lemons; W T Goldsmith; J K Gu; D R Germolec; D H Beezhold; B J Green
Journal:  Clin Exp Allergy       Date:  2016-09-16       Impact factor: 5.018

Review 2.  Circulatory microRNAs: promising non-invasive prognostic and diagnostic biomarkers for parasitic infections.

Authors:  Hossein Ghalehnoei; Abouzar Bagheri; Mahdi Fakhar; Mohammad Amir Mishan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-15       Impact factor: 3.267

Review 3.  Mammalian host microRNA response to plasmodial infection: role as therapeutic target and potential biomarker.

Authors:  Abhinab Mohanty; Vinoth Rajendran
Journal:  Parasitol Res       Date:  2021-08-23       Impact factor: 2.383

Review 4.  Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis.

Authors:  Mohd Saquib; Prachi Agnihotri; Sagarika Biswas
Journal:  Curr Rheumatol Rep       Date:  2021-04-30       Impact factor: 4.592

Review 5.  Non-coding RNAs in malaria infection.

Authors:  Valeria Lodde; Matteo Floris; Maria Rosaria Muroni; Francesco Cucca; Maria Laura Idda
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-10-14       Impact factor: 9.349

Review 6.  Tying malaria and microRNAs: from the biology to future diagnostic perspectives.

Authors:  Mercedes Rubio; Quique Bassat; Xavier Estivill; Alfredo Mayor
Journal:  Malar J       Date:  2016-03-15       Impact factor: 2.979

Review 7.  MicroRNAs in the Host-Apicomplexan Parasites Interactions: A Review of Immunopathological Aspects.

Authors:  Carla C Judice; Catarina Bourgard; Ana C A V Kayano; Letusa Albrecht; Fabio T M Costa
Journal:  Front Cell Infect Microbiol       Date:  2016-02-02       Impact factor: 5.293

Review 8.  Parasite-derived microRNAs as a diagnostic biomarker: potential roles, characteristics, and limitations.

Authors:  Vahid Raissi; Mohammad Zibaei; Omid Raiesi; Zahra Samani; Mohammad Yarahmadi; Soudabeh Etemadi; Afrida Istiqomah; Zahra Alizadeh; Shahrzad Shadabi; Nasrin Sohrabi; Asmaa Ibrahim
Journal:  J Parasit Dis       Date:  2021-04-22

Review 9.  Circulating MicroRNAs as Biomarkers for Sepsis.

Authors:  Fabian Benz; Sanchari Roy; Christian Trautwein; Christoph Roderburg; Tom Luedde
Journal:  Int J Mol Sci       Date:  2016-01-09       Impact factor: 5.923

Review 10.  Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Human Infectious Diseases.

Authors:  Parmila Verma; Rajan K Pandey; Priyanka Prajapati; Vijay K Prajapati
Journal:  Front Microbiol       Date:  2016-08-15       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.